State agencies to identify alternative health care providers.
Health care utilization review procedures.
Review of prospective rate setting methods.
Drug purchasing cost controls—Establishment of evidence-based prescription drug program.
Prescription drug purchasing consortium—Participation—Exceptions—Rules.
Prescription drug consortium account.
Health technology clinical committee.
Health technology selection and assessment.
Health technology clinical committee determinations.
Agency compliance with committee determination—Coverage and reimbursement determinations for nonreviewed health technologies—Appeals.
Health technology clinical committee—Public notice.
Applicability to health care services purchased from health carriers.
Streamlined health care administration—Agency participation.